Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients.
about
Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for preventionPneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis RecommendationsPneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic reviewClinical significance of positive Pneumocystis jirovecii polymerase chain reaction in non-human immunodeficiency virus immunocompromised patients in a real practice.Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study.Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes.Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China.Pneumocystis jirovecii pneumonia in patients with or without AIDS, France.Pneumocystis pneumonia induced by treatment with low-dose tacrolimus and methylprednisolone in a patient with rheumatoid arthritis: a case reportCellular profiles of bronchoalveolar lavage fluid and their prognostic significance for non-HIV-infected patients with Pneumocystis jirovecii pneumonia.Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death.Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.Prognostic factors for severe Pneumocystis jiroveci pneumonia of non-HIV patients in intensive care unit: a bicentric retrospective studyManagement of Pneumocystis pneumonia in patients with inflammatory disorders.Severe pneumonia in the elderly: a multivariate analysis of risk factors.Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia.Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii.Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.Cavitary pulmonary disease.Increasing Pneumocystis pneumonia, England, UK, 2000-2010Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study.Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii on the fully automated BD MAX platformAsymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy.The absence of Hck, Fgr, and Lyn tyrosine kinases augments lung innate immune responses to Pneumocystis murina.Glucocorticosteroid in treatment of severe pneumonia.Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons.Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting.Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases.ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients.High prevalence of Pneumocystis jirovecii colonization among patients with autoimmune inflammatory diseases and corticosteroid therapy.The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis.Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysisPneumocystis jiroveci pneumonia and colonization in patients with advanced lung cancer.Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR.
P2860
Q24791788-90E32823-02D2-41B8-BBA1-7E1500205999Q26781920-FC3D2206-20FE-48D1-8C99-282C190DF838Q26797509-6C4C4C36-C6BA-456A-8D62-1D452CBE49EDQ33690687-4198D16A-DD7E-4279-9972-C5567C0FD2D3Q33768267-697ADF54-8126-4B9E-8438-034DE2DF9175Q33856426-94111A3B-45EE-4CB1-BBE8-54494CABA868Q33910458-CE159641-5B25-40B1-B3A7-3AE665771B66Q34259891-0D363E7A-5A6A-47F4-BDE1-51EE25EDC0E9Q34461860-0879BBEE-BC6B-434B-B689-E06949B7695FQ35193298-4A7EF607-8C9A-40F3-96E6-0AD92E6D14FEQ35793693-130955BD-760F-4134-9C3B-F4701EC6DCCCQ35920640-5941B011-FFF4-4810-A404-C75CDC06223AQ36148851-74BC5240-D5BC-49DB-970D-FA7E98F9E795Q36162376-294BF408-3B49-4566-AF4B-CAC610443039Q36182731-ED234E32-234C-4C15-804C-FBA45DB5B47DQ36211354-E8B6B6F6-07C5-40BF-92A3-69278653B94EQ36297681-87E97542-5A2A-48B6-9850-ECE91A80D67CQ36434896-1720F9DB-B8D0-44CB-A07E-2DFBBF0F276FQ36538804-43D9AB4D-5012-4C93-A6FB-01C0B4B90238Q36826008-337472AE-AC7F-4C0F-B581-A5BB6E36F9DEQ36958088-2D352432-C117-42D7-94E7-C10AE76400B8Q36971085-1DB104E7-8F6B-4B90-A27F-AA1B0346987AQ37096855-20983A69-1F3C-412F-BDFF-9A1B7295095CQ37191294-7AEB5667-0600-455F-BF3C-783467EDB08EQ37398445-C0D801A5-48CC-48AE-B12D-D8CAC8218E8AQ37469079-A9AD1ED1-9829-4BE5-B7ED-6F634053D5F1Q37523896-87A84E1D-534F-430C-9284-7A4BA5E33010Q37734639-E90D83EE-623D-42A8-8B8B-10CF25CE39B6Q38284466-FDFC0CB3-EB9F-4AC5-86DB-7FE80D5A14E5Q38482611-47210194-1189-4978-83AB-88057304CC80Q38934528-898EA34D-BD3F-44CF-87C6-9C2EEC990D89Q39012809-79EE7490-E8FC-4454-B08E-56ED7A5C8C42Q39062899-E39A7BF0-CE0D-488D-8234-A37EF417D15EQ39404140-4D1CA435-BC0E-4FF6-A7CC-F65F2643787FQ39649365-0EAA3799-4B4D-4BDD-A735-B8ACB75D6CA4Q40100993-807DAD53-EF9D-400B-A0DE-DDB8A57AB3C5Q41605436-25D6053F-206F-493F-9623-230D584F5090Q41708606-A079A377-4CCD-430A-B920-A0C98A9F374BQ41837588-07F8DE28-4D0F-425B-943D-71156B8599C1Q41871161-BBF49F19-4AA8-44FA-BE5F-85C88DE66EE0
P2860
Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Analysis of underlying disease ...... romised HIV-negative patients.
@en
Analysis of underlying disease ...... romised HIV-negative patients.
@nl
type
label
Analysis of underlying disease ...... romised HIV-negative patients.
@en
Analysis of underlying disease ...... romised HIV-negative patients.
@nl
prefLabel
Analysis of underlying disease ...... romised HIV-negative patients.
@en
Analysis of underlying disease ...... romised HIV-negative patients.
@nl
P2093
P1476
Analysis of underlying disease ...... romised HIV-negative patients.
@en
P2093
Becq-Giraudon B
De Gentile L
Faouzi Souala M
P2888
P304
P356
10.1007/S10096-002-0758-5
P577
2002-07-13T00:00:00Z